Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis

Abstract

These results highlight the dysfunction that occurs in CD4 T-cell metabolism and immune responses during atherosclerosis. Targeting metabolic pathways within naive CD4 T cells could thus yield novel therapeutic approaches for improving CD4 T-cell responses against atheroprogression.